Scott Dodson has spent 30 years in the medical device space leading organizations from successful IPO’s and exits to globally recognized Fortune 500 companies in every region of the world. He was recently named one of the Top 100 Most Influential Leaders in Healthcare. He has been the President, CEO and Board Member of two venture backed medical device startups and while at AirXpanders, his efforts resulted in an oversubscribed IPO, two follow-on financings and successful commercialization efforts in The United States and Australia. He is well versed in clinical trial management, the FDA process and securing reimbursement through CMS. Scott has led acquisitions, divestitures and conducted diligence on dozens of companies in over 15 different sectors and has raised over $200M in private and public markets around the world.